Açıklama

Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations.

Figure 2

Chart

Source Paper

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel …

Nutrients (2021)

PMID: 34836092

DOI: 10.3390/nu13113836

Cite This Figure

![Figure 2: Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations.]()

> Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." *Nutrients*, 2021. PMID: [34836092](https://pubmed.ncbi.nlm.nih.gov/34836092/)

<figure>
  <img src="" alt="Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations." />
  <figcaption>Figure 2. Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations.<br>  Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." <em>Nutrients</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34836092/">34836092</a></figcaption>
</figure>

İlgili Kanıtlar

Bifidobacterium longum için Irritable Bowel Syndrome (IBS)

Derece B · 4 çalışma

Galactooligosaccharides (GOS) için Irritable Bowel Syndrome (IBS)

Derece B · 3 çalışma